Analysis of lncRNA and mRNA expression profiles in diabetic peripheral neuropathy based on weighted gene co-expression network analysis

References

• Ajjan RA, Schroeder V. 2019. Role of complement in diabetes. Mol Immunol. 114:270–277. doi:10.1016/j.molimm.2019.07.031.
   PubMed Web of Science ®Google Scholar
• Alexander J, Edwards R, Mahdavi A, Baggio T, Parsons B. 2016. Development of an agent-based modeling and simulation platform for improving therapeutic outcomes in patients with painful diabetic peripheral neuropathy. J Pain. 17(4):S19. doi:10.1016/j.jpain.2016.01.077.
   Web of Science ®Google Scholar
• American Diabetes Association. 2020. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 43(Suppl 1):S135–s151. doi:10.2337/dc20-S011.
   PubMedGoogle Scholar
• Bilir B, Ekiz Bilir B, Yilmaz I, Soysal Atile N, Yildirim T, Kara SP, Gumustas SA, Orhan AE, Aydin M. 2016. Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients. Eur Rev Med Pharmacol Sci. 20(5):892–898.
   PubMed Web of Science ®Google Scholar
• Calza L, Fernandez M, Giardino L. 2015. Role of the thyroid system in myelination and neural connectivity. Compr Physiol. 5(3):1405–1421. doi:10.1002/cphy.c140035.
   PubMed Web of Science ®Google Scholar
• Chang W, Wang J. 2019. Exosomes and their noncoding RNA cargo are emerging as new modulators for diabetes mellitus. Cells. 8(8). doi:10.3390/cells8080853
   Web of Science ®Google Scholar
• Chen C, Bai X, Bi Y, Liu G, Li H, Liu Z, Liu H. 2017. Insulin-like growth factor-1 attenuates apoptosis and protects neurochemical phenotypes of dorsal root ganglion neurons with paclitaxel-induced neurotoxicity in vitro. Nutr Neurosci. 20(2):89–102. doi:10.1179/1476830514y.0000000147.
   PubMed Web of Science ®Google Scholar
• Das UN. 2018. Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: a review. J Adv Res. 11:43–55. doi:10.1016/j.jare.2018.01.002.
   PubMed Web of Science ®Google Scholar
• Dewanjee S, Das S, Das AK, Bhattacharjee N, Dihingia A, Dua TK, Kalita J, Manna P. 2018. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur J Pharmacol. 833:472–523. doi:10.1016/j.ejphar.2018.06.034.
   PubMed Web of Science ®Google Scholar
• Feldman EL, Nave KA, Jensen TS, Bennett DLH. 2017. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 93(6):1296–1313. doi:10.1016/j.neuron.2017.02.005.
   PubMed Web of Science ®Google Scholar
• Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, et al. 2012. A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population. PLoS One. 7(9):e46263–e46263. doi:10.1371/journal.pone.0046263.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, Maruyama K, Ueda T, Senba H, Todo Y, et al. 2017. Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: the Dogo study. Int J Impot Res. 29(1):30–34. doi:10.1038/ijir.2016.40.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Sahoo R, Vaidya A, Chorev M, Halperin JA. 2015. Role of complement and complement regulatory proteins in the complications of diabetes. Endocr Rev. 36(3):272–288. doi:10.1210/er.2014-1099.
   PubMed Web of Science ®Google Scholar
• Goncalves NP, Vaegter CB, Andersen H, Ostergaard L, Calcutt NA, Jensen TS. 2017. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol. 13(3):135–147. doi:10.1038/nrneurol.2016.201.
   PubMed Web of Science ®Google Scholar
• Goyal N, Kesharwani D, Datta M. 2018. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. Cell Mol Life Sci. 75(10):1827–1837. doi:10.1007/s00018-018-2760-9.
   PubMed Web of Science ®Google Scholar
• Hernandez A, Martinez ME, Fiering S, Galton VA, St Germain D. 2006. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest. 116(2):476–484. doi:10.1172/jci26240.
   PubMed Web of Science ®Google Scholar
• Hu Y, Yan C, Hsu CH, Chen QR, Niu K, Komatsoulis GA, Meerzaman D. 2014. Omiccircos: a simple-to-use R package for the circular visualization of multidimensional omics data. Cancer Inform. 13:13–20. doi:10.4137/cin.S13495.
   PubMedGoogle Scholar
• Huang X, Liu G, Guo J, Su Z. 2018. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 14(11):1483–1496. doi:10.7150/ijbs.27173.
   PubMed Web of Science ®Google Scholar
• Hummel KP, Dickie MM, Coleman DL. 1966. Diabetes, a new mutation in the mouse. Science. 153(3740):1127–1128. doi:10.1126/science.153.3740.1127.
   PubMed Web of Science ®Google Scholar
• Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U. 2018. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 40(6):828–849. doi:10.1016/j.clinthera.2018.04.001.
   PubMed Web of Science ®Google Scholar
• Jin HY, Park TS. 2018. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J Diabetes Investig. 9(5):1016–1018. doi:10.1111/jdi.12794.
   PubMed Web of Science ®Google Scholar
• Jude EB, Abbott CA, Young MJ, Anderson SG, Douglas JT, Boulton AJ. 1998. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia. 41(3):330–336. doi:10.1007/s001250050911.
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. 2008. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9:559. doi:10.1186/1471-2105-9-559.
   PubMed Web of Science ®Google Scholar
• Leti F, DiStefano JK. 2017. Long noncoding RNAs as diagnostic and therapeutic targets in type 2 diabetes and related complications. Genes (Basel). 8(8):207. doi:10.3390/genes8080207.
   PubMed Web of Science ®Google Scholar
• Leung A, Amaram V, Natarajan R. 2019. Linking diabetic vascular complications with LncRNAs. Vascul Pharmacol. 114:139–144. doi:10.1016/j.vph.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Leung A, Natarajan R. 2018. Long noncoding RNAs in diabetes and diabetic complications. Antioxid Redox Signal. 29(11):1064–1073. doi:10.1089/ars.2017.7315.
   PubMed Web of Science ®Google Scholar
• Marchese FP, Huarte M. 2017. A long noncoding RNA in DNA replication and chromosome dynamics. Cell Cycle (Georgetown, Tex). 16(2):151–152. doi:10.1080/15384101.2016.1241604.
   PubMed Web of Science ®Google Scholar
• Moore EE, Ellsworth JL. n.d. Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use. https://patents.google.com/patent/US8084426B2/en.
   Google Scholar
• Pande M, Hur J, Hong Y, Backus C, Hayes JM, Oh SS, Kretzler M, Feldman EL. 2011. Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. Diabetes. 60(7):1981–1989. doi:10.2337/db10-1541.
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. 2017. Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care. 40(1):136–154. doi:10.2337/dc16-2042.
   PubMed Web of Science ®Google Scholar
• Richner M, Ferreira N, Dudele A, Jensen TS, Vaegter CB, Goncalves NP. 2018. Functional and structural changes of the blood-nerve-barrier in diabetic neuropathy. Front Neurosci. 12:1038. doi:10.3389/fnins.2018.01038.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7):e47. doi:10.1093/nar/gkv007.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. 2019. Temporary removal: global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 107843. doi:10.1016/j.diabres.2019.107843.
   PubMed Web of Science ®Google Scholar
• Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. 2019. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 7(12):938–948. doi:10.1016/s2213-8587(19)30081-6.
   PubMed Web of Science ®Google Scholar
• Sun J, Wang Y, Zhang X, Zhu S, He H. 2020. Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis. Prim Care Diabetes. doi:10.1016/j.pcd.2019.12.005.
   Web of Science ®Google Scholar
• Tautz L, Senis YA, Oury C, Rahmouni S. 2015. Perspective: tyrosine phosphatases as novel targets for antiplatelet therapy. Bioorg Med Chem. 23(12):2786–2797. doi:10.1016/j.bmc.2015.03.075.
   PubMed Web of Science ®Google Scholar
• Truett GE, Tempelman RJ, Walker JA, Wilson JK. 1998. Misty (m) affects growth traits. Am J Physiol. 275(1):R29–R32. doi:10.1152/ajpregu.1998.275.1.R29.
   PubMedGoogle Scholar
• Velez Edwards DR, Naj AC, Monda K, North KE, Neuhouser M, Magvanjav O, Kusimo I, Vitolins MZ, Manson JE, O'Sullivan MJ, et al. 2013. Geneenvironment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe study. Hum Genet. 132(3):323–336. doi:10.1007/s00439-012-1246-3.
   PubMed Web of Science ®Google Scholar
• Vinik AI. 2016. Clinical practice. diabetic sensory and motor neuropathy. New Engl J Med. 374(15):1455–1464. doi:10.1056/NEJMcp1503948.
   PubMedGoogle Scholar
• Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 42(7):579. doi:10.1038/ng.609.
   PubMed Web of Science ®Google Scholar
• Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, Clayton DG. 2010. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet. 42(1):68–71. doi:10.1038/ng.493.
   PubMed Web of Science ®Google Scholar
• Wang S, Hou Y, Chen W, Wang J, Xie W, Zhang X, Zeng L. 2018. KIF9–AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease. Mol Med Report. 17(2):2195–2202. doi:10.3892/mmr.2017.8118.
   PubMed Web of Science ®Google Scholar
• Wang X, Xu B. 2020. Establishment and validation of animal models of peripheral diabetic neuropathies. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 42(5):658–666. doi:10.3881/j.issn.1000-503X.12001.
   PubMedGoogle Scholar
• Wright DE, Johnson MS, Arnett MG, Smittkamp SE, Ryals JM. 2007. Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db/db) mice. J Peripher Nerv Syst. 12(4):250–261. doi:10.1111/j.1529-8027.2007.00144.x.
   PubMed Web of Science ®Google Scholar
• Wu L, Chen L, Li L. 2017. Apelin/APJ system: a novel promising therapy target for pathological angiogenesis. Clin Chim Acta. 466:78–84. doi:10.1016/j.cca.2016.12.023.
   PubMed Web of Science ®Google Scholar
• Yang RH, Lin J, Hou XH, Cao R, Yu F, Liu HQ, Ji AL, Xu XN, Zhang L, Wang F. 2014. Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: involvement of PI3K/AKT/nuclear factor-kappaB-mediated inflammatory pathways. Neuroscience. Aug. 274:218–228. doi:10.1016/j.neuroscience.2014.05.042.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu W, Zeng J, Liu S, Tan X, Aljohi H, Hu S. 2016. Identification and analysis of mouse non-coding RNA using transcriptome data. Sci China Life Sci. 59(6):589–603. doi:10.1007/s11427-015-4929-x.
   PubMed Web of Science ®Google Scholar
• Zilliox LA, Russell JW. 2019. Physical activity and dietary interventions in diabetic neuropathy: a systematic review. Clin Auton Res. 29(4):443–455. doi:10.1007/s10286-019-00607-x.
   PubMed Web of Science ®Google Scholar